Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Lawrence currently holds 13,811 shares of ACORDA THERAPEUTICS INC (ACOR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Lawrence has been a net seller of ACOR stock. They have purchased $0 and sold $11.6M worth of shares.
David Lawrence's most recent insider trade was on Dec 1, 2020, when they sold 1,141 shares at $0.65 per share.
David Lawrence serves as Executive at ACORDA THERAPEUTICS INC (ACOR). They have executed 354 insider transactions totaling $11.6M over their tenure at the company.
David Lawrence holds the position of Executive at ACORDA THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
David Lawrence has shown a selling trading pattern, with $0 in total purchases and $11.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David Lawrence was on Dec 18, 2015, when they sold $1.6M worth of ACOR shares. This transaction involved 38,506 shares at $40.62 per share.
David Lawrence currently owns 13,811 shares of ACORDA THERAPEUTICS INC (ACOR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Lawrence's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Lawrence has 354 Form 4 filings on record as an insider at ACORDA THERAPEUTICS INC.
Set alerts for David Lawrence and 40,000+ other insiders.